Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.123 HKD | -3.15% | -8.89% | -61.56% |
Mar. 28 | Graphex Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 27 | ADRs End Higher; Connect Biopharma Holdings Climbs 21% | DJ |
Valuation
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Capitalization 1 | 300.7 | 110.5 | 110.5 | - |
Enterprise Value (EV) 1 | 300.7 | 287.4 | 110.5 | 110.5 |
P/E ratio | -3.61 x | - | - | - |
Yield | - | - | - | - |
Capitalization / Revenue | - | 0.98 x | 0.31 x | 0.25 x |
EV / Revenue | - | 0.98 x | 0.31 x | 0.25 x |
EV / EBITDA | - | 8.64 x | 2.52 x | 2.02 x |
EV / FCF | - | -2.32 x | -0.62 x | -0.33 x |
FCF Yield | - | -43.2% | -161% | -306% |
Price to Book | - | - | - | - |
Nbr of stocks (in thousands) | 683,493 | 898,571 | 898,571 | - |
Reference price 2 | 0.4400 | 0.1230 | 0.1230 | 0.1230 |
Announcement Date | 3/30/23 | 3/28/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Net sales 1 | - | 291.9 | 355.8 | 443.4 |
EBITDA 1 | - | 33.24 | 43.8 | 54.75 |
EBIT 1 | - | -69.76 | -63.35 | -46.92 |
Operating Margin | - | -23.9% | -17.8% | -10.58% |
Earnings before Tax (EBT) | - | - | - | - |
Net income | -69.66 | - | - | - |
Net margin | - | - | - | - |
EPS | -0.1220 | - | - | - |
Free Cash Flow 1 | - | -47.71 | -178.3 | -337.9 |
FCF margin | - | -14.84% | -50.11% | -76.19% |
FCF Conversion (EBITDA) | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - |
Dividend per Share | - | - | - | - |
Announcement Date | 3/30/23 | 3/28/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 | 2025 S1 | 2025 S2 |
---|---|---|---|---|---|---|
Net sales 1 | - | 140.7 | 162.7 | 193.2 | 212.7 | 231.5 |
EBITDA 1 | - | 13.97 | 21.12 | 21.9 | 27.37 | 28.16 |
EBIT 1 | - | -40.12 | -35.19 | -28.16 | -26.59 | -20.33 |
Operating Margin | - | -28.52% | -21.63% | -14.57% | -12.5% | -8.78% |
Earnings before Tax (EBT) | - | - | - | - | - | - |
Net income | -43.97 | - | - | - | - | - |
Net margin | - | - | - | - | - | - |
EPS | -0.0606 | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 9/28/23 | 3/28/24 | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Net Debt | - | - | - | - |
Net Cash position | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - |
Free Cash Flow 1 | - | -47.7 | -178 | -338 |
ROE (net income / shareholders' equity) | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - |
Assets | - | - | - | - |
Book Value Per Share | - | - | - | - |
Cash Flow per Share | - | - | - | - |
Capex 1 | - | 7.82 | 102 | 250 |
Capex / Sales | - | 2.43% | 28.57% | 56.44% |
Announcement Date | 3/30/23 | 3/28/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-61.56% | 14.12M | |
+11.47% | 63.22B | |
-3.47% | 46.34B | |
+13.72% | 39.97B | |
+17.83% | 25.46B | |
+7.27% | 18.68B | |
-0.57% | 17.24B | |
-21.73% | 15.81B | |
+0.22% | 14.9B | |
-19.10% | 13.74B |
- Stock Market
- Equities
- 6128 Stock
- Financials Graphex Group Limited